OpenAI has announced an investment in Merge Labs, a neurotech startup cofounded by its CEO, Sam Altman. The company emerged from stealth with $252 million in funding, aiming to develop ultrasound-based brain-computer interfaces. OpenAI plans to collaborate on technologies linking human brains to computers.
On Thursday, OpenAI revealed its investment in Merge Labs, a new neurotech venture cofounded by Sam Altman, the billionaire CEO of OpenAI. This funding forms part of a $252 million raise for the startup, which has just come out of stealth mode. Backers include OpenAI alongside other investors, supporting Merge Labs' focus on innovative brain technologies.
Merge Labs seeks to advance neuroscience through ultrasound methods that enable reading from and writing to the brain. This approach positions the company at the intersection of artificial intelligence and brain-computer interfaces. The collaboration between OpenAI and Merge Labs will target the development of systems to connect people's brains directly to computers, potentially expanding human-machine interactions.
Sam Altman's involvement underscores the growing interest in neurotech among AI leaders. As OpenAI's CEO, Altman brings significant expertise to the project, which aligns with broader efforts in the field. The announcement highlights the rapid evolution of startups tackling brain-related innovations, backed by substantial capital to drive research forward.
While details on the exact investment amount from OpenAI remain undisclosed, the partnership signals strong commitment to merging AI with neuroscience. Merge Labs' emergence marks a notable step in the competitive landscape of brain-tech development.
